Pharmaceutical Technology, March 2017 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-02-2017
Volume 41
Issue 3

Click the title above to open the Pharmaceutical Technology March 2017 issue in an interactive PDF format.

External Link - PharmTech_NA_March2017.pdf

Download Issue PDF
Articles in this issue
containment_pyramide-neu_forweb495-New-1486406565450.jpg
Understanding Containment
International Trade Issues Threaten Global Pharma Operations
Oral Delivery of Biologic APIs: The Challenge Continues
Oral Delivery of Biologic APIs: The Challenge Continues
Covering Global Regulations in a Quality System
Risk-Based Predictive Stability–An Industry Perspective
Risk-Based Predictive Stability–An Industry Perspective
Quality Agreements:Managing Global Relationships
Quality Agreements:Managing Global Relationships
Achieving Manufacturing Excellence
Achieving Manufacturing Excellence
GMP Facility Modernization: Opportunities for Successful Implementation
GMP Facility Modernization: Opportunities for Successful Implementation
LoadingBench_225.jpg
Loading Bench for Cold-Chain Management
Deitz_225.jpg
Tabletop Pill Counter Automatically Counts and Fills Solid Oral-Dose Products
Ross_225.jpg
Mixers for Blending Applications
MT_225.jpg
Intelligent Stand for Pipette Management
Integrating Industrial Internet of Things and Pharmaceutical Manufacturing Processes
Integrating Industrial Internet of Things and Pharmaceutical Manufacturing Processes
Strategizing a Shortcut to Market
Industry experts weigh in on FDA’s Quality Metrics program
Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

European Commission Approves BridgeBio Treatment for ATTR-CM

Patrick Lavery
February 12th 2025
Article

Acoramidis was approved by FDA in November 2024 and is prescribed in the US under the brand name Attruby.

Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

L.B. Bohle Wet Granulator to Make US Debut at INTERPHEX

Patrick Lavery
February 11th 2025
Article

The company says it is the pharmaceutical market’s first wet granulator with an integrated, truly continuous dryer.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Black female scientist looking through microscope while working in laboratory. | Image Credit: ©Drazen - stock.adobe.com

The 10th Anniversary of the International Day of Women and Girls in Science

Susan Haigney
February 11th 2025
Article

Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.

Futuristic, AI and business woman, cyber data and connectivity, iot overlay and technology innovation. Digital transformation, tech analytics and mockup space, web dashboard and internet holographic | Image credit: © Angelo/peopleimages.com – stock.adobe.com

Women, STEM, and AI in Pharma

Susan Haigney
February 11th 2025
Article

In a lead up to The International Day of Women and Girls in Science, Pharmaceutical Technology® takes a look at the unique perspective women bring to the use of artificial intelligence in the pharmaceutical industry.